Single-Dose Cardioplegia Protects Myocardium as Well as Traditional Repetitive Dosing: A Noninferiority Randomized Study
The present prospective noninferiority randomized trial was designed to demonstrate the safety and efficacy of a single dose of Custodiol histidine-tryptophan-ketoglutarate compared with repetitive cold-blood cardioplegia.